Importantly, some of these studies have shown that both CD133+ and CD133− cells from the same glioblastoma tumor can exhibit self-renewal in vitro and the capability to generate serially transplantable tumors in immunocompromised mice [273]. The gene discussed is PROM1; the disease is glioblastoma.